CME Group (CME) Stock Price, News & Analysis

Company Overview

CME Group is a leading global derivatives marketplace that offers a wide range of futures and options products across various asset classes. Headquartered in Chicago, Illinois, the company operates four primary exchanges—the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and the Commodity Exchange (COMEX). Through both electronic trading via its CME Globex platform and traditional open-outcry trading floors, CME Group facilitates price discovery, risk management and hedging for participants worldwide.

The company’s product portfolio encompasses interest rate contracts, equity index futures, foreign exchange, agricultural commodities, energy products and metals. Market participants—from institutional investors and commercial hedgers to retail traders—use these instruments to manage exposure and participate in global markets. In addition to trading services, CME Group provides central counterparty clearing through CME Clearing, data and analytics, and post-trade services that support efficient transaction settlement and risk mitigation.

CME Group traces its roots to the Chicago Butter and Egg Board founded in 1898, evolving into the Chicago Mercantile Exchange in the early 20th century. In 2007, it merged with the Chicago Board of Trade, creating one of the world’s largest derivatives exchanges, and further expanded in 2008 with the acquisition of the New York Mercantile Exchange. Over the years, CME Group has broadened its global footprint, establishing regional offices in financial centers such as New York, London, Singapore, Hong Kong and São Paulo to better serve a diverse international clientele.

Under the leadership of Chairman and Chief Executive Officer Terry Duffy, CME Group continues to innovate its technology infrastructure and expand its product offerings. The company adheres to rigorous regulatory standards and collaborates with market participants, regulators and industry bodies to enhance transparency and resilience in the global derivatives markets.

Key Stats

• Today's Range: $264.15 to $269.77
• 50-Day Range: $265.40 to $287.10
• 52-Week Range: $212.38 to $290.79
• Volume: 2.14 million shs
• Average Volume: 1.77 million shs
• Market Capitalization: $97.07 billion
• P/E Ratio: 26.07
• Dividend Yield: 1.86%
• Price Target: $261.93
• Consensus Rating: Hold

CME Group Stock Analysis - MarketRank™

CME Group scored higher than 92% of companies evaluated by MarketBeat, and ranked 134th out of 928 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.0 / 5
• Analyst Rating: Hold

Consensus Rating

CME Group has received a consensus rating of Hold. The company's average rating score is 2.06, and is based on 4 buy ratings, 9 hold ratings, and 3 sell ratings.

Amount of Analyst Coverage

CME Group has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 4.77%

Earnings Growth

Earnings for CME Group are expected to grow by 4.77% in the coming year, from $10.49 to $10.99 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of CME Group is 26.07, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 269.50.

Price to Earnings Ratio vs. Sector

The P/E ratio of CME Group is 26.07, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 228.93.

Price to Earnings Growth Ratio

CME Group has a PEG Ratio of 4.82. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

CME Group has a P/B Ratio of 3.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.42% of the float of CME Group has been sold short.

Short Interest Ratio / Days to Cover

CME Group has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in CME Group has recently decreased by 6.27%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

CME Group pays a meaningful dividend of 1.88%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

CME Group does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of CME Group is 48.40%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, CME Group will have a dividend payout ratio of 45.50% next year. This indicates that CME Group will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 2.9 / 5
• Environmental Score: -0.26

Percentage of Shares Shorted

1.42% of the float of CME Group has been sold short.

Short Interest Ratio / Days to Cover

CME Group has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in CME Group has recently decreased by 6.27%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 1.21

News Sentiment

CME Group has a news sentiment score of 1.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.05 average news sentiment score of Finance companies.

News Coverage This Week

MarketBeat has tracked 38 news articles for CME Group this week, compared to 41 articles on an average week.

Search Interest

Only 7 people have searched for CME on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

MarketBeat Follows

14 people have added CME Group to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, CME Group insiders have sold 4,554.56% more of their company's stock than they have bought. Specifically, they have bought $72,232.00 in company stock and sold $3,362,082.00 in company stock.

Percentage Held by Insiders

Only 0.30% of the stock of CME Group is held by insiders.

Percentage Held by Institutions

87.75% of the stock of CME Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CME Stock Analysis - Frequently Asked Questions

How have CME shares performed this year?

CME Group's stock was trading at $232.23 at the beginning of 2025. Since then, CME stock has increased by 16.0% and is now trading at $269.35.

How were CME Group's earnings last quarter?

CME Group Inc. (NASDAQ:CME) announced its quarterly earnings results on Wednesday, July, 23rd. The financial services provider reported $2.96 EPS for the quarter, beating the consensus estimate of $2.91 by $0.05. The business's revenue was up 10.4% on a year-over-year basis.
Read the conference call transcript.

How will CME Group's stock buyback program work?

CME Group's board authorized a share repurchase plan on Thursday, December 5th 2024, which permits the company to buy back $3,000,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 3.4% of its stock through open market purchases. Stock buyback plans are often an indication that the company's board believes its stock is undervalued.

Who are CME Group's major shareholders?

CME Group's top institutional shareholders include Vanguard Group Inc. (9.76%), State Street Corp (4.56%), Geode Capital Management LLC (2.55%) and Norges Bank (1.58%). Insiders that own company stock include Terrence A Duffy, Bryan T Durkin, Larry G Gerdes, Julie Holzrichter, Hilda Harris Piell, Martin J Gepsman, Julie Winkler, Howard J Siegel, Elizabeth A Cook, Terry L Savage, Terry L Savage, Sunil Cutinho, Daniel R Glickman, Lynne Fitzpatrick, Ken Vroman, Timothy S Bitsberger, Derek Sammann, Suzanne Sprague, Timothy Francis Mccourt, Jonathan L Marcus, Charles P Carey, Daniel G Kaye, Phyllis M Lockett, Dennis Suskind and William R Shepard.
View institutional ownership trends.

How do I buy shares of CME Group?

Shares of CME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of CME Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CME Group investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and Southern First Bancshares (SFST).

Company Calendar

• Record date for 6/25 Dividend: 6/09/2025
• Ex-Dividend for 6/25 Dividend: 6/09/2025
• Dividend Payable: 6/25/2025
• Last Earnings: 7/23/2025
• Today: 9/03/2025
• Record date for 9/25 Dividend: 9/09/2025
• Ex-Dividend for 9/25 Dividend: 9/09/2025
• Dividend Payable: 9/25/2025
• Next Earnings (Estimated): 10/22/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: Securities Exchanges
• Sub-Industry: Specialized Finance
• Current Symbol: NASDAQ:CME
• CIK: 1156375
• Web: www.cmegroup.com
• Phone: (312) 930-1000
• Fax: 312-466-4410
• Employees: 3,760
• Year Founded: 1848

Price Target and Rating

• Average Price Target for CME Group: $261.93
• High Price Target: $305.00
• Low Price Target: $198.00
• Potential Upside/Downside: -2.8%
• Consensus Rating: Hold
• Rating Score (0-4): 2.06
• Research Coverage: 16 Analysts

Profitability

• EPS (Trailing Twelve Months): $10.33
• Trailing P/E Ratio: 26.07
• Forward P/E Ratio: 25.68
• P/E Growth: 4.82
• Net Income: $3.53 billion
• Net Margins: 58.48%
• Pretax Margin: 75.24%
• Return on Equity: 14.60%
• Return on Assets: 2.61%

Debt

• Debt-to-Equity Ratio: 0.12
• Current Ratio: 1.02
• Quick Ratio: 1.02

Sales & Book Value

• Annual Sales: $6.13 billion
• Price / Sales: 15.83
• Cash Flow: $11.46 per share
• Price / Cash Flow: 23.51
• Book Value: $76.97 per share
• Price / Book: 3.50

Miscellaneous

• Outstanding Shares: 360,380,000
• Free Float: 359,299,000
• Market Cap: $97.07 billion
• Optionable: Optionable
• Beta: 0.43